STOCK TITAN

908 Devices Inc. - MASS STOCK NEWS

Welcome to our dedicated page for 908 Devices news (Ticker: MASS), a resource for investors and traders seeking the latest updates and insights on 908 Devices stock.

908 Devices Inc. (Symbol: MASS) is revolutionizing the field of chemical analysis by making mass spectrometry accessible and user-friendly. Headquartered in Boston, the company specializes in developing point-of-need chemical analysis devices that range from rugged handheld tools to compact and efficient analyzers. These devices, based on advanced High Pressure Mass Spectrometry (HPMS), are designed to offer quick, actionable insights into unknown and invisible materials.

908 Devices serves a variety of industries, including safety and security, oil & gas, life sciences, and other applied markets. Their products are purpose-built and user-centric, catering to the specific needs of each market. The company is committed to providing innovative solutions that address critical problems in sectors such as life sciences research, bioprocessing, industrial biotech, and forensics.

In terms of financial performance, 908 Devices derives the bulk of its revenue from the United States, although it also has a significant presence in Europe, the Middle East, Africa, the Americas, and the Asia Pacific region. Recent achievements include the development of a suite of advanced Mass Spec devices that are compact yet highly effective. These devices are designed to be used at the point of need, offering rapid and reliable chemical analysis that is crucial for various applications.

One of the key areas of focus for 908 Devices is to democratize chemical analysis, making it more accessible and easier to use for a broader range of users. By doing so, the company aims to accelerate the pace of innovation and discovery in multiple fields. Their products are not only technologically advanced but also user-friendly, ensuring that even non-experts can operate them effectively.

In the latest news, 908 Devices continues to push the boundaries of what is possible with mass spectrometry. They have recently announced several new partnerships and product launches that aim to further enhance their capabilities and market reach. These developments highlight the company's commitment to staying at the forefront of the chemical analysis industry.

Rhea-AI Summary
908 Devices Inc. (Nasdaq: MASS) reported $35.9 million in revenue for the first nine months of 2023, a 2% increase compared to 2022. The third quarter revenue was $14.3 million, a 9% decrease from the same period last year. The company expects full year 2023 revenue to be in the range of $49 million to $51 million, representing 4% to 9% growth over full year 2022.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.15%
Tags
-
Rhea-AI Summary
908 Devices and Terumo Blood and Cell Technologies announce a collaboration to enable on-line monitoring of critical process parameters in Terumo BCT’s Quantum Flex Cell Expansion System. The collaboration aims to improve manufacturing efficiency and reduce costs in cell and gene therapy development. 908 Devices' MAVEN analyzer will be integrated into the Quantum Flex system to provide real-time monitoring and control of key process parameters.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.15%
Tags
none
-
Rhea-AI Summary
908 Devices Inc. (Nasdaq: MASS) will participate in investor conferences including the 53rd Annual Baird Industrial Conference, Stifel Healthcare Conference 2023, and 25th Annual Stephens Investment Conference. The conferences will feature in-person presentations and fireside chats. Interested parties can access live and archived webcasts on the company website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.95%
Tags
conferences
Rhea-AI Summary
908 Devices Inc. has been awarded $10.4 million in purchase orders from the U.S. Air Force and Air National Guard for its MX908 handheld mass spectrometry device with Aero module. The Aero module enables quick detection of chemical threats. The MX908 device is used to detect drugs, chemical agents, and explosives at trace levels.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.63%
Tags
none
-
Rhea-AI Summary
908 Devices Inc. to report Q3 2023 financial results on November 7, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.18%
Tags
conferences earnings
-
Rhea-AI Summary
908 Devices Inc. enters initial production phase of AVCAD program with partner Smiths Detection, producing 122 systems. The AVCAD is a next-generation chemical detector for the U.S. Department of Defense, featuring the company's HPMS technology. This validates 908 Devices' technology as a new standard for chemical detection.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.83%
Tags
none
Rhea-AI Summary
908 Devices launches MAVERICK, an optical in-line analyzer for bioprocess control using Raman spectroscopy. MAVERICK offers real-time monitoring and control of glucose, lactate, and total biomass in mammalian cell cultures without complex modeling. It provides rich process fingerprint data and can monitor up to six bioreactor modules simultaneously. MAVERICK aims to enhance process understanding and implement dynamic control strategies for faster time to market and more efficient processes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.77%
Tags
none
-
Rhea-AI Summary
908 Devices Inc. (Nasdaq: MASS) to participate in Gilmartin Group Emerging Growth Company Showcase.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.64%
Tags
conferences acquisition
-
Rhea-AI Summary
908 Devices reports 9% increase in revenue for Q2 2023, driven by 27% growth in handheld revenue. Recurring revenue increases by 39% YoY. Net loss of $9.3 million for Q2 2023. Cash, cash equivalents, and marketable securities at $153 million as of June 30, 2023. Full year 2023 revenue expected to be in the range of $49 million to $52 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
22.01%
Tags
Rhea-AI Summary
908 Devices Inc (Nasdaq: MASS) announces that Tennessee law enforcement agencies have chosen to implement the MX908 handheld mass spectrometer to enhance drug identification processes. The pilot program aims to decrease the quantity of controlled substance samples sent to the laboratory, reducing wait times and expediting the judicial process. The MX908's capabilities enable law enforcement officers to ensure individuals prosecuted for drug-related offenses enter drug treatment programs much sooner.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.64%
Tags
partnership

FAQ

What is the current stock price of 908 Devices (MASS)?

The current stock price of 908 Devices (MASS) is $2.06 as of December 20, 2024.

What is the market cap of 908 Devices (MASS)?

The market cap of 908 Devices (MASS) is approximately 66.9M.

What does 908 Devices Inc. specialize in?

908 Devices specializes in developing point-of-need chemical analysis devices based on mass spectrometry.

Where is 908 Devices Inc. headquartered?

908 Devices Inc. is headquartered in Boston, Massachusetts.

What industries does 908 Devices serve?

908 Devices serves industries including safety and security, oil & gas, life sciences, and other applied markets.

What technology is the foundation of 908 Devices' products?

Their products are based on High Pressure Mass Spectrometry (HPMS).

What regions contribute to 908 Devices' revenue?

The company derives most of its revenue from the United States and also has significant presence in Europe, the Middle East, Africa, the Americas, and the Asia Pacific.

What recent achievements has 908 Devices announced?

The company has announced new partnerships and product launches aimed at enhancing their capabilities and market reach.

How does 908 Devices aim to democratize chemical analysis?

908 Devices aims to make chemical analysis more accessible and user-friendly, accelerating innovation and discovery in various fields.

What are Mass Spec devices used for?

Mass Spec devices are used to analyze unknown and invisible materials, providing quick and actionable insights.

Are 908 Devices' products user-friendly?

Yes, their products are designed to be user-friendly, ensuring even non-experts can operate them effectively.

How does 908 Devices contribute to life sciences research?

Their Mass Spec devices provide quick and reliable chemical analysis, critical for life sciences research and bioprocessing.

908 Devices Inc.

Nasdaq:MASS

MASS Rankings

MASS Stock Data

66.86M
32.02M
7.6%
69.75%
3.96%
Medical Devices
Measuring & Controlling Devices, Nec
Link
United States of America
BOSTON